Citation:Maughan TS, Adams RA, Smith CG, Meade AM, Seymour MT, Wilson RH, et al 2011

Citation

Maughan TS, Adams RA, Smith CG, Meade AM, Seymour MT, Wilson RH, et al. Addition of cetuximab to oxaliplatin-based first-line combination chemotherapy for treatment of advanced colorectal cancer: results of the randomised phase 3 MRC COIN trial. Lancet 2011 Jun 18;377(9783):2103-14 Available from: http://www.ncbi.nlm.nih.gov/pubmed/21641636.

Critical appraisals

• Assign a critical appraisal

Cited by

1. Molecular pathology and biomarkers – implications for systemic therapy
2. Role of biological agents in first-line treatment of metastatic colorectal cancer